SlideShare a Scribd company logo
Project Roadmap 2016-2020
Chris Arnold
2@variomeproj
#HVP6
3@variomeproj
#HVP6
Global Collection
Architecture
Membership Growth
– +665 Individual Members (1200+ total)
– +6 Institutional Members (6 total)
– +20 Data Provider Members (60+ total)
Project Wide Initiatives Established
– BRCA Challenge (with Global Alliance for Genomics and Health)
– Global Globin 2020 Challenge
HVP Standards and Guidelines Published
– HVP/GL/001-01/EN: Gene/Disease Specific Variant Database Quality Parameters
– HVP/GL/002-01/EN: Disclaimer Statements for Gene/Disease Specific Databases
– HVP/GL/003-01/EN: Variant Terminology and Exon Numbering
Relationships with Intergovernmental Organisations
– Admitted to Associate Status with UNESCO
– Memorandum of Understanding signed with WHO to work with them to establish a
global program on medical genetics and genomics
Achievements
5@variomeproj
#HVP6
6
Overarching Vision of the Human Variome
Project
A world where the availability of and access to
genomic variant information by both experts and
the general public is not an impediment to
diagnosis and treatment; where the burden of
disease on the human population is significantly
decreased; and where the sharing of genomic
variant information is standard clinical practice.
@variomeproj
#HVP6
7
Goal for 2020
To increase the amount of information about
clinically validated and classified genomic
variants available on the internet in open,
curated databases, by means of cooperation at
the individual, organisational, national, regional
and international levels, so that all people can
benefit from advances in genomic medicine.
@variomeproj
#HVP6
8
To facilitate growth in the
amount of quality curated
genomic variant data that is
publicly available in all regions
of the world, through
developing and consolidating
effective partnerships that
better coordinate data
collection and sharing efforts
across the world.
Objective 1
@variomeproj
#HVP6
9
To support the further
integration of genomics into
mainstream clinical practice
through the development and
promotion of international
standards and best-practice
guidelines.
Objective 2
@variomeproj
#HVP6
10
To encourage meaningful and
substantive advances in
research into the human
variome.
Objective 3
@variomeproj
#HVP6
11
To strengthen national
capacity in genomic variant
data collection and sharing
through both the delivery of
strategic and targeted
training, education and
capacity building programs,
and using effective
partnerships with
organizations sharing common
interests.
Objective 4
@variomeproj
#HVP6
12
To ensure that the next
generation of scientists are
attuned to collecting and
sharing quality genomic
variant data in a manner that
is fair, open, equitable and
sustainable.
Objective 5
@variomeproj
#HVP6
13
Implementation
@variomeproj
#HVP6
• HVP project continuing from strength to strength
• Need to look at a new paradigm for coordination
– based in time zone more able to deal with the multiple global players
• HVPIL wind up 30 June
• UNESCO, WHO affiliation, with coordination function to move
to a new not for profit called Global Variome Ltd,
• Board of HVPIL will move to this new organisation to ensure
continuity and drive both fund raising for sustainability and
collaboration
14@variomeproj
#HVP6
Coordination

More Related Content

What's hot

INTEGRATE AMR - Opportunities to Collaborate with Warwick
INTEGRATE AMR - Opportunities to Collaborate with WarwickINTEGRATE AMR - Opportunities to Collaborate with Warwick
INTEGRATE AMR - Opportunities to Collaborate with Warwick
warwick_amr
 

What's hot (20)

RADx-UP CDCC presentation for the NIH Disaster Interest Group
RADx-UP CDCC presentation for the NIH Disaster Interest GroupRADx-UP CDCC presentation for the NIH Disaster Interest Group
RADx-UP CDCC presentation for the NIH Disaster Interest Group
 
NCI HTAN, cancer trajectories, precision oncology
NCI HTAN, cancer trajectories, precision oncologyNCI HTAN, cancer trajectories, precision oncology
NCI HTAN, cancer trajectories, precision oncology
 
DCHI webinar on N3C January 2021
DCHI webinar on N3C January 2021DCHI webinar on N3C January 2021
DCHI webinar on N3C January 2021
 
Matt Bolz-Johnson: Rare Drug Strategy Webinar
Matt Bolz-Johnson: Rare Drug Strategy Webinar Matt Bolz-Johnson: Rare Drug Strategy Webinar
Matt Bolz-Johnson: Rare Drug Strategy Webinar
 
Population-Scale Research Efforts Enabled by Progress in Sequencing
Population-Scale Research Efforts Enabled by Progress in SequencingPopulation-Scale Research Efforts Enabled by Progress in Sequencing
Population-Scale Research Efforts Enabled by Progress in Sequencing
 
OHDSI OMOP - i2b2 conference Tübingen 2019
OHDSI OMOP - i2b2 conference Tübingen 2019OHDSI OMOP - i2b2 conference Tübingen 2019
OHDSI OMOP - i2b2 conference Tübingen 2019
 
Nci clinical genomics data sharing ncra sept 2016
Nci clinical genomics data sharing ncra sept 2016Nci clinical genomics data sharing ncra sept 2016
Nci clinical genomics data sharing ncra sept 2016
 
INTEGRATE AMR - Opportunities to Collaborate with Warwick
INTEGRATE AMR - Opportunities to Collaborate with WarwickINTEGRATE AMR - Opportunities to Collaborate with Warwick
INTEGRATE AMR - Opportunities to Collaborate with Warwick
 
NCI TEAG Cancer Moonshot Blue Ribbon Panel Presentation Oct 2016
NCI TEAG Cancer Moonshot Blue Ribbon Panel Presentation Oct 2016NCI TEAG Cancer Moonshot Blue Ribbon Panel Presentation Oct 2016
NCI TEAG Cancer Moonshot Blue Ribbon Panel Presentation Oct 2016
 
Global Globin 2020 Challenge: Developing capacity for gene variant data shari...
Global Globin 2020 Challenge: Developing capacity for gene variant data shari...Global Globin 2020 Challenge: Developing capacity for gene variant data shari...
Global Globin 2020 Challenge: Developing capacity for gene variant data shari...
 
Strategy for Rare Diseases in Canada Where are we now? What else is needed?
Strategy for Rare Diseases in Canada Where are we now? What else is needed? Strategy for Rare Diseases in Canada Where are we now? What else is needed?
Strategy for Rare Diseases in Canada Where are we now? What else is needed?
 
Update on local and national survivorship initiatives
Update on local and national survivorship initiativesUpdate on local and national survivorship initiatives
Update on local and national survivorship initiatives
 
CI4CC Moonshot Blue Ribbon Panel Report 20161010
CI4CC Moonshot Blue Ribbon Panel Report 20161010CI4CC Moonshot Blue Ribbon Panel Report 20161010
CI4CC Moonshot Blue Ribbon Panel Report 20161010
 
Converged IT Summit - NCI Data Sharing
Converged IT Summit - NCI Data SharingConverged IT Summit - NCI Data Sharing
Converged IT Summit - NCI Data Sharing
 
Ensuring Values-based Assessments for Innovative Therapies: Brent Fraser (CADTH)
Ensuring Values-based Assessments for Innovative Therapies: Brent Fraser (CADTH)Ensuring Values-based Assessments for Innovative Therapies: Brent Fraser (CADTH)
Ensuring Values-based Assessments for Innovative Therapies: Brent Fraser (CADTH)
 
Day 2: Innovation to optimise therapeutic options for prevention and treatmen...
Day 2: Innovation to optimise therapeutic options for prevention and treatmen...Day 2: Innovation to optimise therapeutic options for prevention and treatmen...
Day 2: Innovation to optimise therapeutic options for prevention and treatmen...
 
Similarities and differences between Rare Cancers and Rare Diseases
Similarities and differences between Rare Cancers and Rare DiseasesSimilarities and differences between Rare Cancers and Rare Diseases
Similarities and differences between Rare Cancers and Rare Diseases
 
The Africa Biosciences Challenge Fund Program
The Africa Biosciences Challenge Fund ProgramThe Africa Biosciences Challenge Fund Program
The Africa Biosciences Challenge Fund Program
 
Update on animal health component 1.1
Update on animal health component 1.1Update on animal health component 1.1
Update on animal health component 1.1
 
OS16 - 1.4.a Encouraging the Use of Vaccination-To-Live as a Control Strate...
OS16 - 1.4.a   Encouraging the Use of Vaccination-To-Live as a Control Strate...OS16 - 1.4.a   Encouraging the Use of Vaccination-To-Live as a Control Strate...
OS16 - 1.4.a Encouraging the Use of Vaccination-To-Live as a Control Strate...
 

Similar to Project Roadmap 2016-2020 - Chris Arnold

Use of open, curated variant databases: ethics? Liability? - Bartha Knoppers
Use of open, curated variant databases: ethics? Liability? - Bartha KnoppersUse of open, curated variant databases: ethics? Liability? - Bartha Knoppers
Use of open, curated variant databases: ethics? Liability? - Bartha Knoppers
Human Variome Project
 
Creating successful partnerships in yorkshire and humber
Creating successful partnerships in yorkshire and humberCreating successful partnerships in yorkshire and humber
Creating successful partnerships in yorkshire and humber
PM Society
 
Creating successful partnerships in yorkshire and humber
Creating successful partnerships in yorkshire and humberCreating successful partnerships in yorkshire and humber
Creating successful partnerships in yorkshire and humber
PM Society
 
Engaging people living with hiv in citizen monitoring in mali
Engaging people living with hiv in citizen monitoring in maliEngaging people living with hiv in citizen monitoring in mali
Engaging people living with hiv in citizen monitoring in mali
Dr Lendy Spires
 

Similar to Project Roadmap 2016-2020 - Chris Arnold (20)

Use of open, curated variant databases: ethics? Liability? - Bartha Knoppers
Use of open, curated variant databases: ethics? Liability? - Bartha KnoppersUse of open, curated variant databases: ethics? Liability? - Bartha Knoppers
Use of open, curated variant databases: ethics? Liability? - Bartha Knoppers
 
Hannes Smarason: Progress & Prospects in Genomics
Hannes Smarason: Progress & Prospects in GenomicsHannes Smarason: Progress & Prospects in Genomics
Hannes Smarason: Progress & Prospects in Genomics
 
CCDI Kibbe Wake Forest University Dec 2023.pptx
CCDI Kibbe Wake Forest University Dec 2023.pptxCCDI Kibbe Wake Forest University Dec 2023.pptx
CCDI Kibbe Wake Forest University Dec 2023.pptx
 
CCDI Kibbe Big Data Training May 2022
CCDI Kibbe Big Data Training May 2022CCDI Kibbe Big Data Training May 2022
CCDI Kibbe Big Data Training May 2022
 
Analysis of EU – Brazil cooperation opportunities on teleHealth
Analysis of EU – Brazil cooperation opportunities on teleHealthAnalysis of EU – Brazil cooperation opportunities on teleHealth
Analysis of EU – Brazil cooperation opportunities on teleHealth
 
National Cancer Data Ecosystem and Data Sharing
National Cancer Data Ecosystem and Data SharingNational Cancer Data Ecosystem and Data Sharing
National Cancer Data Ecosystem and Data Sharing
 
AHA SHAPE Symposium 2017 Dr. Greenland Presentation
AHA SHAPE Symposium 2017 Dr. Greenland PresentationAHA SHAPE Symposium 2017 Dr. Greenland Presentation
AHA SHAPE Symposium 2017 Dr. Greenland Presentation
 
Whole Genome Sequencing (WGS) for food safety management-Perspectives from C...
Whole Genome Sequencing (WGS)  for food safety management-Perspectives from C...Whole Genome Sequencing (WGS)  for food safety management-Perspectives from C...
Whole Genome Sequencing (WGS) for food safety management-Perspectives from C...
 
NCI Cancer Genomics, Open Science and PMI: FAIR
NCI Cancer Genomics, Open Science and PMI: FAIR NCI Cancer Genomics, Open Science and PMI: FAIR
NCI Cancer Genomics, Open Science and PMI: FAIR
 
Super computing 19 Cancer Computing Workshop Keynote
Super computing 19 Cancer Computing Workshop KeynoteSuper computing 19 Cancer Computing Workshop Keynote
Super computing 19 Cancer Computing Workshop Keynote
 
Decade of Vaccines Collaboration Overview - September 2011
Decade of Vaccines Collaboration Overview - September 2011Decade of Vaccines Collaboration Overview - September 2011
Decade of Vaccines Collaboration Overview - September 2011
 
Creating successful partnerships in yorkshire and humber
Creating successful partnerships in yorkshire and humberCreating successful partnerships in yorkshire and humber
Creating successful partnerships in yorkshire and humber
 
Creating successful partnerships in yorkshire and humber
Creating successful partnerships in yorkshire and humberCreating successful partnerships in yorkshire and humber
Creating successful partnerships in yorkshire and humber
 
Data Commons & Data Science Workshop
Data Commons & Data Science WorkshopData Commons & Data Science Workshop
Data Commons & Data Science Workshop
 
Rare Disease Patient Registries: Key to Drug Development and Access Webinar ...
Rare Disease Patient Registries:  Key to Drug Development and Access Webinar ...Rare Disease Patient Registries:  Key to Drug Development and Access Webinar ...
Rare Disease Patient Registries: Key to Drug Development and Access Webinar ...
 
Engaging Patients in Research and Tool Development
Engaging Patients in Research and Tool DevelopmentEngaging Patients in Research and Tool Development
Engaging Patients in Research and Tool Development
 
CCDI Overview November 2022
CCDI Overview November 2022CCDI Overview November 2022
CCDI Overview November 2022
 
Day 1: 9:15am-10:45am Panel Slides (Nov 18) Access to Innovation Conference
Day 1: 9:15am-10:45am Panel Slides (Nov 18) Access to Innovation ConferenceDay 1: 9:15am-10:45am Panel Slides (Nov 18) Access to Innovation Conference
Day 1: 9:15am-10:45am Panel Slides (Nov 18) Access to Innovation Conference
 
TransCelerate Overview - Clinical Research Access & Information Exchange Ini...
TransCelerate Overview -  Clinical Research Access & Information Exchange Ini...TransCelerate Overview -  Clinical Research Access & Information Exchange Ini...
TransCelerate Overview - Clinical Research Access & Information Exchange Ini...
 
Engaging people living with hiv in citizen monitoring in mali
Engaging people living with hiv in citizen monitoring in maliEngaging people living with hiv in citizen monitoring in mali
Engaging people living with hiv in citizen monitoring in mali
 

More from Human Variome Project

ClinVar: Aggregating Data to Improve Variant Interpretation - Melissa Landrum
ClinVar: Aggregating Data to Improve Variant Interpretation - Melissa LandrumClinVar: Aggregating Data to Improve Variant Interpretation - Melissa Landrum
ClinVar: Aggregating Data to Improve Variant Interpretation - Melissa Landrum
Human Variome Project
 
Legal and regulatory challenges to data sharing for clinical genetics and ge...
Legal and regulatory challenges to  data sharing for clinical genetics and ge...Legal and regulatory challenges to  data sharing for clinical genetics and ge...
Legal and regulatory challenges to data sharing for clinical genetics and ge...
Human Variome Project
 
Human variome project quality assessment criteria for variation databases - M...
Human variome project quality assessment criteria for variation databases - M...Human variome project quality assessment criteria for variation databases - M...
Human variome project quality assessment criteria for variation databases - M...
Human Variome Project
 
GENETIC HETEROGENEITY OF MITOCHONDRIAL DISORDERS - Agnès Rötig
GENETIC HETEROGENEITY OF MITOCHONDRIAL DISORDERS - Agnès RötigGENETIC HETEROGENEITY OF MITOCHONDRIAL DISORDERS - Agnès Rötig
GENETIC HETEROGENEITY OF MITOCHONDRIAL DISORDERS - Agnès Rötig
Human Variome Project
 

More from Human Variome Project (20)

ClinVar: Aggregating Data to Improve Variant Interpretation - Melissa Landrum
ClinVar: Aggregating Data to Improve Variant Interpretation - Melissa LandrumClinVar: Aggregating Data to Improve Variant Interpretation - Melissa Landrum
ClinVar: Aggregating Data to Improve Variant Interpretation - Melissa Landrum
 
The BRCA Share(TM) Consortium - Christophe Beroud
The BRCA Share(TM) Consortium - Christophe BeroudThe BRCA Share(TM) Consortium - Christophe Beroud
The BRCA Share(TM) Consortium - Christophe Beroud
 
Establishing validity, reproducibility, and utility of highly scalable geneti...
Establishing validity, reproducibility, and utility of highly scalable geneti...Establishing validity, reproducibility, and utility of highly scalable geneti...
Establishing validity, reproducibility, and utility of highly scalable geneti...
 
The PhenX Toolkit: Standard Measures for Collaborative Research - Wayne Huggins
The PhenX Toolkit: Standard Measures for  Collaborative Research - Wayne HugginsThe PhenX Toolkit: Standard Measures for  Collaborative Research - Wayne Huggins
The PhenX Toolkit: Standard Measures for Collaborative Research - Wayne Huggins
 
Legal and regulatory challenges to data sharing for clinical genetics and ge...
Legal and regulatory challenges to  data sharing for clinical genetics and ge...Legal and regulatory challenges to  data sharing for clinical genetics and ge...
Legal and regulatory challenges to data sharing for clinical genetics and ge...
 
Report from the International Confederation of Countries Advisory Council - M...
Report from the International Confederation of Countries Advisory Council - M...Report from the International Confederation of Countries Advisory Council - M...
Report from the International Confederation of Countries Advisory Council - M...
 
Human variome project quality assessment criteria for variation databases - M...
Human variome project quality assessment criteria for variation databases - M...Human variome project quality assessment criteria for variation databases - M...
Human variome project quality assessment criteria for variation databases - M...
 
HVP Country Node: Venezuela - Aida Falcon de Vargas
HVP Country Node: Venezuela - Aida Falcon de VargasHVP Country Node: Venezuela - Aida Falcon de Vargas
HVP Country Node: Venezuela - Aida Falcon de Vargas
 
Human Genetics of Infectious Diseases - Laurent Abel
Human Genetics of Infectious Diseases - Laurent AbelHuman Genetics of Infectious Diseases - Laurent Abel
Human Genetics of Infectious Diseases - Laurent Abel
 
HVP Country Node: Malaysia - Zilfalil bin Alwi
HVP Country Node: Malaysia - Zilfalil bin AlwiHVP Country Node: Malaysia - Zilfalil bin Alwi
HVP Country Node: Malaysia - Zilfalil bin Alwi
 
GENETIC HETEROGENEITY OF MITOCHONDRIAL DISORDERS - Agnès Rötig
GENETIC HETEROGENEITY OF MITOCHONDRIAL DISORDERS - Agnès RötigGENETIC HETEROGENEITY OF MITOCHONDRIAL DISORDERS - Agnès Rötig
GENETIC HETEROGENEITY OF MITOCHONDRIAL DISORDERS - Agnès Rötig
 
The BRCA Challenge & Exchange: Progress and Plans - Gunnar Rätsch
The BRCA Challenge & Exchange: Progress and Plans - Gunnar RätschThe BRCA Challenge & Exchange: Progress and Plans - Gunnar Rätsch
The BRCA Challenge & Exchange: Progress and Plans - Gunnar Rätsch
 
Richard GH Cotton: He may have been a bit before his time - Michael Watson
Richard GH Cotton: He may have been a bit before his time - Michael WatsonRichard GH Cotton: He may have been a bit before his time - Michael Watson
Richard GH Cotton: He may have been a bit before his time - Michael Watson
 
Professor Richard Cotton - Finlay Macrae
Professor Richard Cotton - Finlay MacraeProfessor Richard Cotton - Finlay Macrae
Professor Richard Cotton - Finlay Macrae
 
HVP Country Node: Canada - Matthew Lebo
HVP Country Node: Canada - Matthew LeboHVP Country Node: Canada - Matthew Lebo
HVP Country Node: Canada - Matthew Lebo
 
HVP6: Final Thoughts - John Burn & Raj Ramesar
HVP6: Final Thoughts - John Burn & Raj RamesarHVP6: Final Thoughts - John Burn & Raj Ramesar
HVP6: Final Thoughts - John Burn & Raj Ramesar
 
Report from the International Scientific Advisory Committee - John Burn
Report from the International Scientific Advisory Committee - John BurnReport from the International Scientific Advisory Committee - John Burn
Report from the International Scientific Advisory Committee - John Burn
 
HVP Country Node: Italy - Domenico Coviello
HVP Country Node: Italy - Domenico CovielloHVP Country Node: Italy - Domenico Coviello
HVP Country Node: Italy - Domenico Coviello
 
Rare and common variants contribute to the complex inheritance of Hirschsprun...
Rare and common variants contribute to the complex inheritance of Hirschsprun...Rare and common variants contribute to the complex inheritance of Hirschsprun...
Rare and common variants contribute to the complex inheritance of Hirschsprun...
 
Report from the Gene & Disease Specific Database Advisory Council - Peter Ta...
Report from the  Gene & Disease Specific Database Advisory Council - Peter Ta...Report from the  Gene & Disease Specific Database Advisory Council - Peter Ta...
Report from the Gene & Disease Specific Database Advisory Council - Peter Ta...
 

Recently uploaded

ESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptxESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptx
muralinath2
 
Pests of Green Manures_Bionomics_IPM_Dr.UPR.pdf
Pests of Green Manures_Bionomics_IPM_Dr.UPR.pdfPests of Green Manures_Bionomics_IPM_Dr.UPR.pdf
Pests of Green Manures_Bionomics_IPM_Dr.UPR.pdf
PirithiRaju
 
Anemia_ different types_causes_ conditions
Anemia_ different types_causes_ conditionsAnemia_ different types_causes_ conditions
Anemia_ different types_causes_ conditions
muralinath2
 
Gliese 12 b: A Temperate Earth-sized Planet at 12 pc Ideal for Atmospheric Tr...
Gliese 12 b: A Temperate Earth-sized Planet at 12 pc Ideal for Atmospheric Tr...Gliese 12 b: A Temperate Earth-sized Planet at 12 pc Ideal for Atmospheric Tr...
Gliese 12 b: A Temperate Earth-sized Planet at 12 pc Ideal for Atmospheric Tr...
Sérgio Sacani
 
RNA INTERFERENCE: UNRAVELING GENETIC SILENCING
RNA INTERFERENCE: UNRAVELING GENETIC SILENCINGRNA INTERFERENCE: UNRAVELING GENETIC SILENCING
RNA INTERFERENCE: UNRAVELING GENETIC SILENCING
AADYARAJPANDEY1
 

Recently uploaded (20)

Lab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerinLab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerin
 
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
 
Microbial Type Culture Collection (MTCC)
Microbial Type Culture Collection (MTCC)Microbial Type Culture Collection (MTCC)
Microbial Type Culture Collection (MTCC)
 
ESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptxESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptx
 
Pests of Green Manures_Bionomics_IPM_Dr.UPR.pdf
Pests of Green Manures_Bionomics_IPM_Dr.UPR.pdfPests of Green Manures_Bionomics_IPM_Dr.UPR.pdf
Pests of Green Manures_Bionomics_IPM_Dr.UPR.pdf
 
Anemia_ different types_causes_ conditions
Anemia_ different types_causes_ conditionsAnemia_ different types_causes_ conditions
Anemia_ different types_causes_ conditions
 
Structures and textures of metamorphic rocks
Structures and textures of metamorphic rocksStructures and textures of metamorphic rocks
Structures and textures of metamorphic rocks
 
GLOBAL AND LOCAL SCENARIO OF FOOD AND NUTRITION.pptx
GLOBAL AND LOCAL SCENARIO OF FOOD AND NUTRITION.pptxGLOBAL AND LOCAL SCENARIO OF FOOD AND NUTRITION.pptx
GLOBAL AND LOCAL SCENARIO OF FOOD AND NUTRITION.pptx
 
Gliese 12 b: A Temperate Earth-sized Planet at 12 pc Ideal for Atmospheric Tr...
Gliese 12 b: A Temperate Earth-sized Planet at 12 pc Ideal for Atmospheric Tr...Gliese 12 b: A Temperate Earth-sized Planet at 12 pc Ideal for Atmospheric Tr...
Gliese 12 b: A Temperate Earth-sized Planet at 12 pc Ideal for Atmospheric Tr...
 
SAMPLING.pptx for analystical chemistry sample techniques
SAMPLING.pptx for analystical chemistry sample techniquesSAMPLING.pptx for analystical chemistry sample techniques
SAMPLING.pptx for analystical chemistry sample techniques
 
Transport in plants G1.pptx Cambridge IGCSE
Transport in plants G1.pptx Cambridge IGCSETransport in plants G1.pptx Cambridge IGCSE
Transport in plants G1.pptx Cambridge IGCSE
 
RNA INTERFERENCE: UNRAVELING GENETIC SILENCING
RNA INTERFERENCE: UNRAVELING GENETIC SILENCINGRNA INTERFERENCE: UNRAVELING GENETIC SILENCING
RNA INTERFERENCE: UNRAVELING GENETIC SILENCING
 
Hemoglobin metabolism: C Kalyan & E. Muralinath
Hemoglobin metabolism: C Kalyan & E. MuralinathHemoglobin metabolism: C Kalyan & E. Muralinath
Hemoglobin metabolism: C Kalyan & E. Muralinath
 
Gliese 12 b, a temperate Earth-sized planet at 12 parsecs discovered with TES...
Gliese 12 b, a temperate Earth-sized planet at 12 parsecs discovered with TES...Gliese 12 b, a temperate Earth-sized planet at 12 parsecs discovered with TES...
Gliese 12 b, a temperate Earth-sized planet at 12 parsecs discovered with TES...
 
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
 
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATIONPRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
 
INSIGHT Partner Profile: Tampere University
INSIGHT Partner Profile: Tampere UniversityINSIGHT Partner Profile: Tampere University
INSIGHT Partner Profile: Tampere University
 
Richard's entangled aventures in wonderland
Richard's entangled aventures in wonderlandRichard's entangled aventures in wonderland
Richard's entangled aventures in wonderland
 
biotech-regenration of plants, pharmaceutical applications.pptx
biotech-regenration of plants, pharmaceutical applications.pptxbiotech-regenration of plants, pharmaceutical applications.pptx
biotech-regenration of plants, pharmaceutical applications.pptx
 
Topography and sediments of the floor of the Bay of Bengal
Topography and sediments of the floor of the Bay of BengalTopography and sediments of the floor of the Bay of Bengal
Topography and sediments of the floor of the Bay of Bengal
 

Project Roadmap 2016-2020 - Chris Arnold

  • 4. Membership Growth – +665 Individual Members (1200+ total) – +6 Institutional Members (6 total) – +20 Data Provider Members (60+ total) Project Wide Initiatives Established – BRCA Challenge (with Global Alliance for Genomics and Health) – Global Globin 2020 Challenge HVP Standards and Guidelines Published – HVP/GL/001-01/EN: Gene/Disease Specific Variant Database Quality Parameters – HVP/GL/002-01/EN: Disclaimer Statements for Gene/Disease Specific Databases – HVP/GL/003-01/EN: Variant Terminology and Exon Numbering Relationships with Intergovernmental Organisations – Admitted to Associate Status with UNESCO – Memorandum of Understanding signed with WHO to work with them to establish a global program on medical genetics and genomics Achievements
  • 6. 6 Overarching Vision of the Human Variome Project A world where the availability of and access to genomic variant information by both experts and the general public is not an impediment to diagnosis and treatment; where the burden of disease on the human population is significantly decreased; and where the sharing of genomic variant information is standard clinical practice. @variomeproj #HVP6
  • 7. 7 Goal for 2020 To increase the amount of information about clinically validated and classified genomic variants available on the internet in open, curated databases, by means of cooperation at the individual, organisational, national, regional and international levels, so that all people can benefit from advances in genomic medicine. @variomeproj #HVP6
  • 8. 8 To facilitate growth in the amount of quality curated genomic variant data that is publicly available in all regions of the world, through developing and consolidating effective partnerships that better coordinate data collection and sharing efforts across the world. Objective 1 @variomeproj #HVP6
  • 9. 9 To support the further integration of genomics into mainstream clinical practice through the development and promotion of international standards and best-practice guidelines. Objective 2 @variomeproj #HVP6
  • 10. 10 To encourage meaningful and substantive advances in research into the human variome. Objective 3 @variomeproj #HVP6
  • 11. 11 To strengthen national capacity in genomic variant data collection and sharing through both the delivery of strategic and targeted training, education and capacity building programs, and using effective partnerships with organizations sharing common interests. Objective 4 @variomeproj #HVP6
  • 12. 12 To ensure that the next generation of scientists are attuned to collecting and sharing quality genomic variant data in a manner that is fair, open, equitable and sustainable. Objective 5 @variomeproj #HVP6
  • 14. • HVP project continuing from strength to strength • Need to look at a new paradigm for coordination – based in time zone more able to deal with the multiple global players • HVPIL wind up 30 June • UNESCO, WHO affiliation, with coordination function to move to a new not for profit called Global Variome Ltd, • Board of HVPIL will move to this new organisation to ensure continuity and drive both fund raising for sustainability and collaboration 14@variomeproj #HVP6 Coordination